迈威生物-B(02493)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02493 迈威生物-B

未开盘 10-30 16:08:06

18.230

-0.370

-1.99%

最高18.470	最低17.800	成交量29.10万
今开17.940	昨收18.600	日振幅3.60%
总市值81.49亿	流通市值8.59亿	总股本4.47亿
成交额536.08万	换手率0.62%	流通股本4,713万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02493","market":"HK","secType":"STK","nameCN":"迈威生物-B","latestPrice":18.23,"timestamp":1793347686870,"preClose":18.6,"halted":0,"volume":291000,"delay":0,"changeRate":-0.019892473118279623,"floatShares":47130200,"shares":447000000,"eps":-2.43,"marketStatus":"未开盘","change":-0.37,"latestTime":"10-30 16:08:06","open":17.94,"high":18.47,"low":17.8,"amount":5360792,"amplitude":0.036022,"askPrice":18.34,"askSize":1200,"bidPrice":18.23,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-2.422,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":0,"adr":0,"listingDate":1777305600000,"exchange":"SEHK","adjPreClose":18.6,"openAndCloseTimeList":[[1793323800000,1793332800000],[1793336400000,1793347200000]],"volumeRatio":2.1690518759290565,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688062","market":"SH","secType":"STK","nameCN":"迈威生物-U","latestPrice":20.03,"timestamp":1793343600000,"preClose":21.35,"halted":0,"volume":10965300,"delay":0,"premium":"-22.82"}},"requestUrl":"/m/hq/s/02493","defaultTab":"news","newsList":[{"id":"2680964207","title":"股市必读：迈威生物新发布《迈威生物关于召开2026年第三季度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680964207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680964207?lang=zh_cn&edition=full","pubTime":"2026-11-02 02:46","pubTimestamp":1793558791,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，迈威生物报收于20.03元，下跌6.18%，换手率2.74%，成交量10.97万手，成交额2.27亿元。当日关注点交易信息汇总：10月30日主力资金净流出2969.99万元，占总成交额13.09%。公司公告汇总：迈威生物将于2026年11月9日14:00-15:00通过“价值在线”平台召开2026年第三季度业绩说明会。投资者可通过指定网址或微信扫描小程序码参与互动，会前提问截止时间为2026年11月9日。说明会结束后可通过平台查看召开情况及主要内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679934292","title":"10月30日迈威生物跌6.18%，中航优选领航混合发起A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679934292","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679934292?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:53","pubTimestamp":1793350403,"startTime":"0","endTime":"0","summary":"证券之星消息，10月30日迈威生物跌6.18%创60日新低，收盘报20.03元，换手率2.74%，成交量10.97万手，成交额2.27亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为中航基金的中航优选领航混合发起A。中航优选领航混合发起A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000041344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193705526","title":"迈威生物-B（02493）定于11月9日举办2026年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1193705526","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193705526?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:25","pubTimestamp":1793276729,"startTime":"0","endTime":"0","summary":"迈威（上海）生物科技股份有限公司10月29日在香港联交所发布海外监管公告称，公司将于2026年11月9日14:00-15:00通过“价值在线”以网络互动方式召开2026年第三季度业绩说明会。公告显示，公司已于2026年10月29日在上海证券交易所网站披露2026年第三季度报告。本次说明会旨在帮助投资者进一步了解公司经营业绩及发展战略，并就投资者普遍关注的问题进行解答。说明会结束后，投资者可通过“价值在线”或“易董”App查看会议情况及主要内容。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679048334","title":"迈威生物：关于召开2026年第三季度业绩说明会的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2679048334","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679048334?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:02","pubTimestamp":1793275320,"startTime":"0","endTime":"0","summary":"    证券日报网讯 10月29日，迈威生物发布公告称，公司计划于2026年11月9日14:00-15:00举行2026年第三季度业绩说明会。 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681256309.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681256309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679403994","title":"迈威生物9月30日股东户数1.86万户，较上期增加0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679403994","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679403994?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:58","pubTimestamp":1793271480,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迈威生物披露，截至2026年9月30日公司股东户数为1.86万户，较6月30日增加100.0户，增幅为0.54%。户均持股数量由上期的2.17万股减少至2.15万股，户均持股市值为58.24万元 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681253493.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681253493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678616004","title":"迈威生物-B(02493)前三季度实现营业收入约6.21亿元 同比增长9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678616004","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678616004?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:13","pubTimestamp":1793186031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈威生物-B 公布2026年前三季度业绩，营业收入约6.21亿元，同比增长9.77%;归属于上市公司股东的净亏损约6.78亿元，基本每股亏损1.6元。国内市场，2026年第三季度实现药品销售收入约1.23亿元，同比增长122.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678461607","title":"迈威生物-B(02493.HK)前三季度实现营业收入约6.21亿元 同比增长9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678461607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678461607?lang=zh_cn&edition=full","pubTime":"2026-10-28 19:13","pubTimestamp":1793186031,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678465576","title":"迈威生物2026年前三季度净亏损6.78亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678465576","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678465576?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:35","pubTimestamp":1793183700,"startTime":"0","endTime":"0","summary":"北京商报讯(记者王寅浩宋雨盈)10月28日，迈威生物发布2026年三季报，前三季度公司实现营业收入6.21亿元，同比增长9.77%；归属于上市公司股东的净亏损为6.78亿元，上年同期为亏损5.98亿元； ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261028/c681200178.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261028/c681200178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678435457","title":"迈威生物：第三季度亏损扩大至1.57亿元 营收同比降33.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678435457","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678435457?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:39","pubTimestamp":1793180340,"startTime":"0","endTime":"0","summary":"10月28日，迈威生物(688062)公布2026年三季报，公司营业收入为6.21亿元，同比上升9.8%；归母净利润自去年同期亏损5.98亿元变为亏损6.78亿元，亏损额进一步扩大；扣非归母净利润自去年同期亏损6.22亿元变为亏损6.83亿元，亏损额进一步扩大；经营现金流净额为-7.45亿元，同比下降622.9%；EPS(全面摊薄)为-1.5186元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610283912106294.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610283912106294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677903107","title":"迈威生物（688062）10月23日主力资金净卖出680.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677903107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677903107?lang=zh_cn&edition=full","pubTime":"2026-10-24 08:20","pubTimestamp":1792801207,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，迈威生物报收于22.82元，上涨4.73%，换手率4.17%，成交量9.61万手，成交额2.1亿元。近5日资金流向一览见下表：迈威生物融资融券信息显示，融资方面，当日融资买入872.98万元，融资偿还1185.03万元，融资净偿还312.05万元。迈威生物主营业务：研发、生产以及销售创新型药物和生物类似药,以高效创新研发和产业化能力为支撑,通过治疗用生物制品的市场推广和销售获得商业利润。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400006897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688062","BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677459839","title":"港股异动 | 迈威生物-B(02493.HK)涨近3% 将于ESMO 2026大会上以口头报告形式报告9MW2821临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2677459839","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677459839?lang=zh_cn&edition=full","pubTime":"2026-10-23 14:57","pubTimestamp":1792738656,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676500213","title":"迈威生物将在2026年ESMO口头报告9MW2821三阴性乳腺癌II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2676500213","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676500213?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:50","pubTimestamp":1792407000,"startTime":"0","endTime":"0","summary":"10月19日，迈威(上海)生物科技股份有限公司将于2026年10月23日至10月27日在西班牙马德里举行的2026年欧洲肿瘤内科学会(ESMO)大会上，以口头报告形式公布靶向Nectin-4ADC创新药9MW2821用于既 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261019/c680846796.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261019/c680846796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189484390","title":"迈威生物-B拟在2026年ESMO大会口头报告9MW2821治疗三阴性乳腺癌II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1189484390","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189484390?lang=zh_cn&edition=full","pubTime":"2026-10-19 18:26","pubTimestamp":1792405571,"startTime":"0","endTime":"0","summary":"迈威（上海）生物科技股份有限公司10月19日公告称，公司将于2026年10月23日至10月27日在西班牙马德里举行的2026年欧洲肿瘤内科学会年会上，以口头报告形式公布靶向Nectin-4抗体偶联药物9MW2821用于既往接受过以拓扑异构酶I抑制剂为载荷ADC治疗的局部晚期或转移性三阴性乳腺癌患者II期临床研究结果。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665504","title":"迈威生物（688062）披露9MW2821在ESMO大会以口头报告形式公布II期临床数据，10月19日股价上涨1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665504?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:26","pubTimestamp":1792402016,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，迈威生物报收于22.56元，较前一交易日上涨1.21%，最新总市值为100.78亿元。迈威生物于近日自愿披露关于9MW2821在2026年欧洲肿瘤内科学会以口头报告形式报告临床数据的公告。公告显示，公司自主研发的靶向Nectin-4的ADC药物9MW2821，在2026年欧洲肿瘤内科学会大会上以口头报告形式公布针对既往接受过以拓扑异构酶I抑制剂为载荷的ADC治疗的局部晚期或转移性三阴性乳腺癌患者的II期临床研究数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900022278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","02493","688062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676111578","title":"股市必读：迈威生物新发布《国泰海通证券股份有限公司关于迈威（上海）生物科技股份有限公司首次公开发行部分限售股上市流通的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676111578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676111578?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:42","pubTimestamp":1792345331,"startTime":"0","endTime":"0","summary":"迈威生物首次公开发行部分限售股上市流通公告迈威（上海）生物科技股份有限公司首次公开发行部分限售股将于2026年10月28日上市流通，数量为169,360,000股，占公司A股股本的42.38%，占公司总股本的37.91%；涉及股东4名，包括朗润（深圳）股权投资基金企业等；限售期为股票上市之日起3个完整会计年度，因公司上市后6个月内股价低于发行价，锁定期自动延长6个月；相关股东已履行股份锁定承诺，保荐机构对本次限售股上市流通无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02611","BK1161","BK0028","161027","BK0276","BK0184","BK0012","BK1147","601211","BK1564","02493","BK0183","BK0188","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676211025","title":"迈威生物：9MW2821临床数据将在2026年ESMO大会口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2676211025","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676211025?lang=zh_cn&edition=full","pubTime":"2026-10-18 15:49","pubTimestamp":1792309768,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675337534","title":"股市必读：迈威生物新发布《国泰海通证券股份有限公司关于迈威（上海）生物科技股份有限公司首次公开发行部分限售股上市流通的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675337534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675337534?lang=zh_cn&edition=full","pubTime":"2026-10-16 01:39","pubTimestamp":1792085948,"startTime":"0","endTime":"0","summary":"公司公告汇总国泰海通证券股份有限公司关于迈威（上海）生物科技股份有限公司首次公开发行部分限售股上市流通的核查意见迈威（上海）生物科技股份有限公司首次公开发行部分限售股将于2026年10月28日起上市流通。本次上市流通的限售股数量为169,360,000股，占公司A股股本的42.38%，占公司总股本的37.91%。相关股东已履行股份锁定承诺，保荐机构对本次限售股上市流通无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600002136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","02493","BK1147","601211","BK0201","BK0183","02611","BK0276","BK1161","161027","BK0184","BK0188","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185969246","title":"迈威生物-B（02493）1.69亿股首发限售股将于2026年10月28日解禁上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1185969246","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185969246?lang=zh_cn&edition=full","pubTime":"2026-10-15 20:35","pubTimestamp":1792067730,"startTime":"0","endTime":"0","summary":"迈威生物-B10月16日在上海证券交易所及香港联交所同步公告，公司将有1.6936亿股首发限售股份于2026年10月28日起上市流通。该批股份占公司A股股份数量的42.38%，占公司总股本的37.91%。\\n\\n迈威生物首发上市后，总股本由399,600,000股增至446,730,200股。\\n\\n保荐机构国泰海通证券股份有限公司已出具核查意见，确认相关股东已严格履行承诺，本次限售股上市流通符合《上海证券交易所科创板股票上市规则》等规定。保荐机构对本次解禁无异议。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675861965","title":"迈威生物：1.69亿股限售股10月28日解禁，占总股本37.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675861965","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675861965?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:33","pubTimestamp":1792060380,"startTime":"0","endTime":"0","summary":"南财智讯10月15日电，迈威生物公告，公司首次公开发行部分限售股1.69亿股将于10月28日上市流通，占公司总股本的37.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610153897040842.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610153897040842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02493","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142182387","title":"迈威生物-B（02493）拟于10月28日召开董事会审议截至9月30日的九个月业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1142182387","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142182387?lang=zh_cn&edition=full","pubTime":"2026-10-15 16:57","pubTimestamp":1792054625,"startTime":"0","endTime":"0","summary":"迈威生物-B（02493）10月15日公告称，公司董事会已订于2026年10月28日（星期三）召开会议，届时将审议及批准本集团截至2026年9月30日止九个月之第三季度业绩，并处理其他事项。\n公告显示，公司现任董事包括：执行董事唐春山、董事长兼执行董事刘大涛、执行董事武海、执行董事华俊及执行董事桂勋；独立非执行董事秦正余、周睿、李凡及王芳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02493"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mabwell.com","stockEarnings":[{"period":"1week","weight":-0.0505},{"period":"1month","weight":-0.1193},{"period":"3month","weight":-0.1327},{"period":"6month","weight":-0.2978},{"period":"1year","weight":-0.3404},{"period":"ytd","weight":-0.3404}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.0536},{"period":"3month","weight":-0.1001},{"period":"6month","weight":-0.0963},{"period":"1year","weight":-0.1137},{"period":"ytd","weight":-0.0911}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"公司是一家全产业链布局的创新型生物制药公司,始终秉承“让创新从梦想变成现实”的愿景,践行“探索生命,惠及健康”的使命,通过源头创新,为患者提供疗效更好、可及性更强的生物创新药,满足全球未被满足的临床需求。公司主营业务为研发、生产以及销售创新型药物和生物类似药。公司主要产品为抗体、ADC药物和重组蛋白、小分子化学药等药物。公司荣誉:上海产业人才队伍建设工作“优秀案例奖”、澳洲会计师公会“认可雇主”、星耀榜“2021中国生物创新药最具成长性年度大奖”、中国医药人才品牌榜总榜及最具竞争力品牌等。","exchange":"SEHK","name":"迈威生物-B","nameEN":"MABWELL-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈威生物-B(02493)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈威生物-B(02493)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈威生物-B,02493,迈威生物-B股票,迈威生物-B股票老虎,迈威生物-B股票老虎国际,迈威生物-B行情,迈威生物-B股票行情,迈威生物-B股价,迈威生物-B股市,迈威生物-B股票价格,迈威生物-B股票交易,迈威生物-B股票购买,迈威生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈威生物-B(02493)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈威生物-B(02493)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}